Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SAVA Cassava Sciences Inc

已收盘 07-26 16:00:00 EDT

14.92

+2.17

+17.02%

盘后14.85

-0.07-0.47%

19:57 EDT

最高14.94	最低12.86	成交量365.94万
今开12.94	昨收12.75	日振幅16.31%
总市值7.16亿	流通市值6.71亿	总股本4,798万
成交额5,110万	换手率8.14%	流通股本4,498万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SAVA","market":"US","secType":"STK","nameCN":"Cassava Sciences Inc","latestPrice":14.92,"timestamp":1722024000000,"preClose":12.75,"halted":0,"volume":3659379,"hourTrading":{"tag":"盘后","latestPrice":14.8503,"preClose":14.92,"latestTime":"19:57 EDT","volume":24890,"amount":370117.9443,"timestamp":1722038264987},"delay":0,"floatShares":44983110,"shares":47976166,"eps":-2.1719,"marketStatus":"已收盘","marketStatusCode":5,"change":2.17,"latestTime":"07-26 16:00:00 EDT","open":12.94,"high":14.94,"low":12.86,"amount":51097665.478920005,"amplitude":0.163137,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.1719,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"adjPreClose":12.75,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":12.9,"preClose":12.75,"latestTime":"09:28 EDT","volume":8028,"amount":102648.681324,"timestamp":1722000512345},"postHourTrading":{"tag":"盘后","latestPrice":14.8503,"preClose":14.92,"latestTime":"19:57 EDT","volume":24890,"amount":370117.9443,"timestamp":1722038264987},"volumeRatio":0.978837,"impliedVol":1.5509,"impliedVolPercentile":0.9206},"requestUrl":"/m/hq/s/SAVA","defaultTab":"news","newsList":[{"id":"2454323413","title":"木薯科学盘中异动 早盘股价大涨5.02%报13.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454323413","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454323413?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:53","pubTimestamp":1722001984,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时53分，木薯科学股票出现波动，股价急速上涨5.02%。截至发稿，该股报13.39美元/股，成交量24.1922万股，换手率0.50%，振幅4.00%。木薯科学股票所在的生物技术行业中，整体涨幅为0.14%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726215304af9459e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726215304af9459e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4547","BK4588","BK4585","SAVA"],"gpt_icon":0},{"id":"2454809892","title":"木薯科学盘中异动 临近午盘快速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454809892","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454809892?lang=zh_cn&edition=full","pubTime":"2024-07-25 23:49","pubTimestamp":1721922563,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日23时49分，木薯科学股票出现波动，股价急速拉升5.04%。截至发稿，该股报12.30美元/股，成交量47.9534万股，换手率1.00%，振幅5.63%。木薯科学股票所在的生物技术行业中，整体跌幅为0.26%。公司的研究诊断产品候选是SavaDx，它是一种从少量血液样本中检测阿尔茨海默病存在的新方法，可能在临床症状明显出现前几年。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725234923941faa9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725234923941faa9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAVA","BK4007","BK4588","BK4547","BK4585"],"gpt_icon":1},{"id":"2453066427","title":"木薯科学盘中异动 下午盘股价大跌5.07%报12.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453066427","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453066427?lang=zh_cn&edition=full","pubTime":"2024-07-24 02:26","pubTimestamp":1721759209,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日02时26分，木薯科学股票出现异动，股价急速下跌5.07%。截至发稿，该股报12.18美元/股，成交量172.036万股，换手率3.59%，振幅8.34%。木薯科学股票所在的生物技术行业中，整体涨幅为0.03%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724022650af93b135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724022650af93b135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","SAVA","BK4547","BK4007","BK4588"],"gpt_icon":1},{"id":"2453797395","title":"BUZZ--美国股票走势-威瑞森通信、Reddit、星巴克","url":"https://stock-news.laohu8.com/highlight/detail?id=2453797395","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453797395?lang=zh_cn&edition=full","pubTime":"2024-07-22 23:54","pubTimestamp":1721663649,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      7月22日 - 在拜登总统退出竞选后，投资者对共和党提名人特朗普在 11 月大选中连任的可能性进行了评估。美东时间11:37，道琼斯工业平均指数  持平于40,289.04点。标普500指数  上涨0.52%，报5533.54点；纳斯达克综合指数  上涨0.73%，报17856.568点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQV","MEIP","PSQ","DOG","LU1303367103.USD","RDDT","SBUX","UDOW","SAVA","DJX","S","GL","SQQQ","TXG","LU1974910355.USD","CHRW","IPG","CLW","VSTO","LU1718418525.SGD","MNQmain",".DJI","BKNG","QID","BUZZ","VZ","ZS","SNDR","TQQQ","GT","QLD",".SPX","NQmain","LU2133065610.SGD",".IXIC","DDM","DXD","SDOW","NEM"],"gpt_icon":1},{"id":"2453579318","title":"木薯科学盘中异动 股价大涨6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453579318","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453579318?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:31","pubTimestamp":1721655068,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时31分，木薯科学股票出现异动，股价大幅拉升6.15%。截至发稿，该股报10.70美元/股，成交量10.3121万股，换手率0.21%，振幅0.79%。木薯科学股票所在的生物技术行业中，整体涨幅为0.60%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722213109941f929d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722213109941f929d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4547","SAVA","BK4007"],"gpt_icon":0},{"id":"2453764193","title":"BUZZ-木薯公司业绩增长；该公司预计将于 12 月公布阿尔茨海默氏症药物的后期试验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2453764193","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453764193?lang=zh_cn&edition=full","pubTime":"2024-07-22 20:30","pubTimestamp":1721651435,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    7月22日 - ** 药物开发商Cassava Sciences   股价盘前上涨4.2%至10.50美元** 该公司称其阿尔茨海默氏症药物 simufilam 的首个后期试验数据 (link) 将于 12 月公布。** 补充说，评估该药物的第二项后期试验将于 2025 年 6 月结束** 截至上次收盘，该股今年累计下跌 55.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAVA","BK4007","BK4585","BK4547","BUZZ","BK4588"],"gpt_icon":0},{"id":"2452871944","title":"木薯科学盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452871944","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452871944?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:04","pubTimestamp":1721311491,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时04分，木薯科学股票出现波动，股价急速拉升5.02%。截至发稿，该股报10.05美元/股，成交量105.677万股，换手率2.20%，振幅6.03%。木薯科学股票所在的生物技术行业中，整体涨幅为0.03%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182204519681e172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182204519681e172&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4547","SAVA","BK4588","BK4585"],"gpt_icon":0},{"id":"2452540511","title":"木薯科学盘中异动 股价大跌26.02%报10.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452540511","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452540511?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:31","pubTimestamp":1721223112,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时31分，木薯科学股票出现波动，股价快速下跌26.02%。截至发稿，该股报10.01美元/股，成交量296.24万股，换手率6.17%，振幅5.32%。木薯科学股票所在的生物技术行业中，整体跌幅为0.74%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071721315295cedd0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071721315295cedd0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","SAVA","BK4547","BK4007","BK4139"],"gpt_icon":1},{"id":"2452159330","title":"盘前暴跌逾30%！Cassava CEO离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2452159330","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452159330?lang=zh_cn&edition=full","pubTime":"2024-07-17 20:50","pubTimestamp":1721220605,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Cassava Sciences周三宣布了管理层变动，Richard Barry接任公司首席执行官兼董事会执行主席。消息传出后，Cassava周三美股盘前暴跌逾30%。此外，Cassava神经科学高级副总裁Lindsay Burns也将离开公司。Barry自2021年6月以来一直担任Cassava的董事。自2015年6月以来，他还担任生物技术公司Sarepta Therapeutics的董事;2019年6月至2020年10月，他担任生物制药公司MiMedx Group的董事。另外，Cassava表示，正在审查其披露做法，以确保向利益相关者提供清晰全面的信息。","market":"us","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152296.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"管理层大变动！Cassava CEO离职","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SAVA","BK4007","BK4547","BK4585","BK4588"],"gpt_icon":1},{"id":"2452151196","title":"盘前暴跌逾30%！Cassava(SAVA.US)CEO离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2452151196","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452151196?lang=zh_cn&edition=full","pubTime":"2024-07-17 20:40","pubTimestamp":1721220000,"startTime":"0","endTime":"0","summary":"Cassava Sciences周三宣布了管理层变动，Richard Barry接任公司首席执行官兼董事会执行主席。消息传出后，Cassava周三美股盘前暴跌逾30%。随着新CEO的任命，董事会计划将董事长和CEO的角色分开。此外，Cassava神经科学高级副总裁Lindsay Burns也将离开公司。Barry自2021年6月以来一直担任Cassava的董事。自2015年6月以来，他还担任生物技术公司Sarepta Therapeutics的董事;2019年6月至2020年10月，他担任生物制药公司MiMedx Group的董事。另外，Cassava表示，正在审查其披露做法，以确保向利益相关者提供清晰全面的信息。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/hkstocknews/2024-07-17/doc-incemyqs0237242.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkstocknews/2024-07-17/doc-incemyqs0237242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4547","BK4585","SAVA","BK4588","BK4007"],"gpt_icon":0},{"id":"2452153098","title":"生物技术公司 Cassava Sciences 首席执行官卸任","url":"https://stock-news.laohu8.com/highlight/detail?id=2452153098","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452153098?lang=zh_cn&edition=full","pubTime":"2024-07-17 20:10","pubTimestamp":1721218215,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透7月17日 - Cassava Sciences   周三表示，首席执行官Remi Barbier已经辞职，该生物技术公司任命Richard Barry为临时首席执行官。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAVA"],"gpt_icon":0},{"id":"2452910151","title":"木薯科学盘中异动 大幅拉升5.43%报13.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452910151","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452910151?lang=zh_cn&edition=full","pubTime":"2024-07-17 00:38","pubTimestamp":1721147904,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日00时38分，木薯科学股票出现波动，股价急速拉升5.43%。截至发稿，该股报13.00美元/股，成交量96.594万股，换手率2.01%，振幅7.62%。木薯科学股票所在的生物技术行业中，整体涨幅为0.11%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717003824af929c6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717003824af929c6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAVA","BK4588","BK4007","BK4585","BK4547"],"gpt_icon":0},{"id":"2451625653","title":"木薯科学盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451625653","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451625653?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:06","pubTimestamp":1721052376,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日22时06分，木薯科学股票出现异动，股价快速上涨5.01%。截至发稿，该股报12.09美元/股，成交量29.0398万股，换手率0.61%，振幅3.65%。木薯科学股票所在的生物技术行业中，整体涨幅为0.42%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715220617af926602&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715220617af926602&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4588","SAVA","BK4007","BK4585"],"gpt_icon":0},{"id":"2450813802","title":"木薯科学盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450813802","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450813802?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:39","pubTimestamp":1720618780,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时39分，木薯科学股票出现波动，股价大幅拉升5.19%。截至发稿，该股报12.15美元/股，成交量21.9008万股，换手率0.46%，振幅7.71%。木薯科学股票所在的生物技术行业中，整体涨幅为0.07%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213941941f5d40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213941941f5d40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LGVN","VRPX","BK4139","SAVA","BK4547","BK4585","BK4588"],"gpt_icon":0},{"id":"2450236080","title":"木薯科学盘中异动 急速上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450236080","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450236080?lang=zh_cn&edition=full","pubTime":"2024-07-09 21:51","pubTimestamp":1720533064,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日21时51分，木薯科学股票出现波动，股价快速拉升5.18%。截至发稿，该股报10.35美元/股，成交量29.9275万股，换手率0.62%，振幅5.59%。木薯科学股票所在的生物技术行业中，整体跌幅为0.57%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709215104aef8baed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709215104aef8baed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","SAVA","BK4547","BK4588"],"gpt_icon":0},{"id":"2449702624","title":"木薯科学盘中异动 大幅下跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449702624","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449702624?lang=zh_cn&edition=full","pubTime":"2024-07-08 23:20","pubTimestamp":1720452019,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日23时20分，木薯科学股票出现波动，股价急速下挫5.53%。截至发稿，该股报9.65美元/股，成交量108.843万股，换手率2.27%，振幅8.22%。木薯科学股票所在的生物技术行业中，整体涨幅为0.80%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082320229681ab05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082320229681ab05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRPX","BK4547","BK4588","BK4007","SAVA","BK4585"],"gpt_icon":0},{"id":"2449216659","title":"木薯科学盘中异动 下午盘急速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449216659","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449216659?lang=zh_cn&edition=full","pubTime":"2024-07-06 02:50","pubTimestamp":1720205431,"startTime":"0","endTime":"0","summary":"北京时间2024年07月06日02时50分，木薯科学股票出现波动，股价急速跳水5.01%。截至发稿，该股报10.23美元/股，成交量191.552万股，换手率3.99%，振幅7.80%。木薯科学股票所在的生物技术行业中，整体涨幅为0.98%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706025032941f47d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706025032941f47d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4007","BK4547","SAVA","BK4588"],"gpt_icon":0},{"id":"2449075204","title":"港股异动 | 绿叶制药(02186)现涨近3% 米美欣(羟考酮纳洛酮缓释片)在中国获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2449075204","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449075204?lang=zh_cn&edition=full","pubTime":"2024-07-05 09:34","pubTimestamp":1720143268,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，绿叶制药(02186)现涨近3%，截至发稿，涨2.84%，报2.9港元，成交额392.59万港元。消息面上，绿叶制药公告，集团镇痛领域新产品－米美欣(羟考酮纳洛酮缓释片，LY021702)已于2024年6月28日获得中国国家药品监督管理局的上市批准，适用于成人需阿片类镇痛药才能充分控制的重度疼痛(癌痛和非癌痛)。据悉，米美欣是当前唯一一款在国内获批上市、具有高技术壁垒的国产羟考酮纳洛酮缓释片。公司相信，米美欣解决了当前的临床需求，在中国具备良好的市场潜力。同时，该产品可与集团的抗肿瘤产品形成丰富的产品组合，并协同肿瘤领域现有的资源与优势，加速推动公司在该领域布局和发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1145958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK1583","BK4007","HSCEI","02186","BK4585","HSTECH","BK1191","SAVA","BK4547","07226","BK4588","YANG"],"gpt_icon":0},{"id":"2448449493","title":"绿叶制药(02186)：米美欣®(羟考酮纳洛酮缓释片)在中国获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2448449493","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448449493?lang=zh_cn&edition=full","pubTime":"2024-07-04 19:03","pubTimestamp":1720091010,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿叶制药 发布公告，集团镇痛领域新产品-米美欣已于2024年6月28日获得中华人民共和国国家药品监督管理局的上市批准，适用于成人需阿片类镇痛药才能充分控制的重度疼痛。米美欣是当前唯一一款在国内获批上市、具有高技术壁垒的国产羟考酮纳洛酮缓释片。除了用于癌痛管理之外，羟考酮纳洛酮缓释片还在多项临床试验中证实能为肌肉骨胳疼痛、术后疼痛、腰痛等中重度疼痛患者提供有效镇痛治疗，并可显著改善患者的便秘。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1145785.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK4585","BK4007","BK1191","BK4547","02186","SAVA","BK4588","BK1583"],"gpt_icon":0},{"id":"2448484836","title":"木薯科学盘中异动 快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448484836","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448484836?lang=zh_cn&edition=full","pubTime":"2024-07-03 23:11","pubTimestamp":1720019465,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日23时11分，木薯科学股票出现波动，股价大幅下跌5.00%。木薯科学股票所在的生物技术行业中，整体跌幅为1.88%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。根据TipRanks数据显示，该分析师近一年总胜率为25.9%，总平均回报率为6.9%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703231105af90689f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703231105af90689f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAVA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cassavasciences.com","stockEarnings":[{"period":"1week","weight":0.2525},{"period":"1month","weight":-0.339},{"period":"3month","weight":-0.4293},{"period":"6month","weight":-0.4738},{"period":"1year","weight":-0.3638},{"period":"ytd","weight":-0.4336}],"compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0118},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.1046},{"period":"1year","weight":0.182},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cassava Sciences, Inc.是一家致力于开发新药的生物制药企业。公司主要候选药物称为羟考酮 (oxycodone) 缓释胶囊 。羟考酮是功效强大的止痛药，其独特的配方有助于减少非计划用量的潜在威胁。羟考酮和其他三种非滥用止疼药是按照与国王制药股份有限公司（King Pharmaceuticals, Inc.）的合作以及许可证协议（Pfizer Agreements）开发研制的。国王制药股份有限公司是辉瑞制药股份有限公司（Pfizer, Inc.）的子公司。公司于1998年5月在特拉华州注册成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.541667,"avgChangeRate":0.155421},{"month":2,"riseRate":0.416667,"avgChangeRate":0.028198},{"month":3,"riseRate":0.458333,"avgChangeRate":0.024377},{"month":4,"riseRate":0.583333,"avgChangeRate":0.060573},{"month":5,"riseRate":0.416667,"avgChangeRate":0.028089},{"month":6,"riseRate":0.458333,"avgChangeRate":-0.016342},{"month":7,"riseRate":0.458333,"avgChangeRate":-0.031182},{"month":8,"riseRate":0.458333,"avgChangeRate":0.001895},{"month":9,"riseRate":0.583333,"avgChangeRate":0.111686},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.042533},{"month":11,"riseRate":0.625,"avgChangeRate":0.025539},{"month":12,"riseRate":0.375,"avgChangeRate":0.049835}],"exchange":"NASDAQ","name":"Cassava Sciences Inc","nameEN":"Cassava Sciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cassava Sciences Inc(SAVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cassava Sciences Inc,SAVA,Cassava Sciences Inc股票,Cassava Sciences Inc股票老虎,Cassava Sciences Inc股票老虎国际,Cassava Sciences Inc行情,Cassava Sciences Inc股票行情,Cassava Sciences Inc股价,Cassava Sciences Inc股市,Cassava Sciences Inc股票价格,Cassava Sciences Inc股票交易,Cassava Sciences Inc股票购买,Cassava Sciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cassava Sciences Inc(SAVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}